Who owns Bayview Acquisition Corp (BAYA)? Elite investor 13F holders
2 tracked elite investors reported holding Bayview Acquisition Corp as of 2026-06-30, including Kahn Brothers Group, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Financials · Financial Services
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care;…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Kahn Brothers Group | Bayer AG Spons ADR | SHARE | 2026-06-30 | 2026-08-17 00:00:00 | 89307717.00 USD | 6518603.000000 | Shares | add | Original filing |
| Ancora Advisors / Ancora Holdings | Bayer AG Spons ADR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 9727.00 USD | 710.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.